Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patients.
CONCLUSION: The results suggest that vaccinating home care patients could potentially be cost-saving from the health care and service producer's perspectives. The uncertainty from the decision-making perspective was due to the large variation in individual costs.
PMID: 30114939 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Finland Health | Health Management | Influenza | Influenza Vaccine | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Research | Study | Vaccines